Table 4.
Dromedaries N = 72 |
% | Appendix S1: Technical appendix reference[Link] |
Other species N = 37 |
% | Appendix S1: Technical appendix reference[Link] | |
---|---|---|---|---|---|---|
Characteristics reported | ||||||
Age | 38 | 52.78 | 6, 9, 10, 12, 14, 15, 18–22, 24, 26, 27, 35–37, 39, 41, 43, 44, 46, 48, 51–53, 60, 61, 63, 65–70, 72, 73 | 13 | 35.14 | 1, 5, 8, 10, 14, 30, 32, 38, 51–53, 65, 71 |
Sex | 22 | 30.56 | 10, 12, 15, 21, 22, 24, 26, 32, 39, 46, 51–53, 60, 63, 66, 67–70, 72, 73 | 9 | 24.32 | 1, 5, 8, 10, 32, 51–53, 71 |
Breed | 1 | 1.39 | 29 | 2 | 5.41 | 10, 14 |
Location (below country level) | 68 | 94.44 | 3, 6, 9–15, 18–22, 24–26, 29, 31, 32, 35–37, 39, 41–45, 48, 51–53, 60, 63, 65–70, 72, 73 | 22 | 59.46 | 1–10, 12, 14, 16, 32–34, 38, 40, 51–53, 56, 58, 59, 65, 70, 71 |
Group size | 42 | 58.33 | 11, 13, 18, 19, 21, 22, 41–44, 46, 51–53, 61, 69, 72, 73 | 5 | 13.51 | 32, 38, 51–53 |
Animal contact/herd structure described | 13 | 18.06 | 6, 18, 21, 22, 24, 37, 41, 43, 53, 61, 65, 69, 73 | 4 | 10.81 | 6, 53, 59, 71 |
Sampling points | ||||||
Primary production (farms/herds/backyard) | 51 | 70.83 | 6, 11, 13, 18, 19, 21, 22, 24, 26, 29, 31, 35, 41, 43, 48, 51–53, 61, 63, 65, 67, 69, 70, 72, 73 | 7 | 18.92 | 3, 38, 40, 51–53, 65 |
Abattoir | 15 | 20.83 | 3, 16, 20, 26, 29, 31, 36, 37, 42, 44, 45, 48, 63, 69, 70 | 1 | 2.70 | 3 |
Live animal market | 4 | 5.56 | 37, 48, 63, 70 | 1 | 2.70 | 59 |
Other[Link] | 8 | 11.11 | 31, 32, 37, 42, 45, 46, 63, 70 | 11 | 29.73 | 2, 4–7, 30, 32, 33, 47, 58, 71 |
Multiple sampling points | 10 | 13.89 | 26, 29, 31, 37, 42, 45, 48, 63, 69, 70 | 1 | 2.70 | 59 |
Each OIE MERS‐CoV animal event entered in EMPRES‐i was treated as a separate record in the review, but were included under one bibliographic entry, per FAO citation protocol.
Other sampling points included wild habitat; zoo; border crossing and trade‐related gathering point; hunting village; wild meat restaurant; veterinary hospital; quarantine.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.